Cargando…
Drug‐Induced Liver Injury by Selective Androgenic Receptor Modulators
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
Autores principales: | Flores, Joan Ericka, Chitturi, Shivakumar, Walker, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049679/ https://www.ncbi.nlm.nih.gov/pubmed/32140660 http://dx.doi.org/10.1002/hep4.1456 |
Ejemplares similares
-
Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator
por: Weinblatt, Daniel, et al.
Publicado: (2022) -
Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator
por: Bedi, Harjot, et al.
Publicado: (2021) -
Selective Androgen Receptor Modulators: An Emerging Liver Toxin
por: Mohideen, Haseeb, et al.
Publicado: (2023) -
Selective Androgen Receptor Modulators (SARMs)-Induced Liver Injury: A Case Report and Review of Literature
por: Mohamed, Wael T, et al.
Publicado: (2023) -
Selective Androgen Receptor Modulator Induced Hepatotoxicity
por: Khan, Sohaib, et al.
Publicado: (2022)